22nd European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID)
31.03.2012 - 03.04.2012

1. Please select a day:

Personal programme

Please enter your email address here in order to bring up your personal programme

Tuesday, April 03, 2012

- Click on a checkbox to select a whole session.
- Session titles which are underlined can be clicked upon to show further details.
- Individual programme items can also be selected.
- Go to another day to select further points or click on display to show your saved personal programme.

	07:45	Best indicators for measuring the success of hand hygiene promotion (Meet-the-Expert)
	07:45	Understanding parasite serology (Meet-the-Expert)
	07:45	CMV infection in critically ill patients (Meet-the-Expert)
	07:45	Infectious complications of new biologic therapies (Meet-the-Expert)
	07:45	Fungal taxonomy for the clinician in 2012 (Meet-the-Expert)
	09:00	Clinical Grand Round (Official Symposium)
	09:00	Controversies in infection control of multidrug-resistant organisms (Official Symposium)
	09:00	The epidemiology and clinical relevance of Clostridium difficile in specific populations (Official Symposium)
	09:00	MALDI-TOF; what is new? (Official Symposium)
	09:00	ISF symposium and presentation of the International Sepsis Forum Award What's new in sepsis? (Official Symposium)
	09:00	Understanding pathogenesis and epidemiology by genomics and proteomics (Oral session)
	09:00	HIV infection (Oral session)
	09:00	Weighing the evidence: a new standard in rapid broad microbial identification (Abbott Symposium)
	09:00	Recent advances towards comprehensive prevention of meningococcal disease (Novartis Symposium)
	09:00	Diagnostic management of hepatitis B: a new role for HBsAg assay (DiaSorin Symposium)
	11:30	ESCMID Young Investigator Award lectures (Keynote Lecture)
	11:30	CMV disease and prevention (Keynote Lecture)
	11:30	Quorum sensing and quorum sensing inhibitors (Official Symposium)
	11:30	Common European curricula and assessment: just a dream? (Official Symposium)
	11:30	Does modelling help to predict outbreaks? - PRO/CON debate (Official Symposium)
	11:30	Chagas disease 2012: now getting global (Official Symposium)
	11:30	Developing new antituberculous drugs (Official Symposium)
	11:30	Hepatitis (Oral Session)
	11:30	Prevention and therapy of MRSA infection (oral session)
	12:30	POSTER SESSION VI
	12:30	AIDS and HIV infection (Postersession)
	12:30	Bacterial pathogenesis: from intracellular bacteria to biofilm (Postersession)
	12:30	Pathogenesis of Gram-positive bacteria (Postersession)
	12:30	Pathogenesis of Gram-negative bacteria (Postersession)
	12:30	Biomarkers of inflammation (Postersession)
	12:30	Clinical experience with antibiotics (Postersession)
	12:30	Clostridium difficile (Postersession)
	12:30	Clostridium difficile - diagnosis, pathogenesis and epidemiology (Postersession)
	12:30	Clostridium difficile - diagnostics and therapy (Postersession)
	12:30	Hepatitis (Postersession)
	12:30	Improving the detection of beta-lactamases (Postersession)
	12:30	MALDI-TOF in the bacteriology lab (Postersession)
	12:30	MRSA - detection and prevention (Postersession)
	12:30	Controlling S.aureus infections in hospitals (Postersession)
	12:30	New aspects of toxoplasmosis, Chagas, malaria and leishmaniasis (Postersession)
	13:30	AFTERNOON SESSIONS
	13:30	Flu, mutations and transmission: to publish or not to publish? (Official Symposium)
	13:30	Cost efficiency of molecular techniques (Official Symposium)
	13:30	Preparing for infectious diseases at the London 2012 Olympic Games (Official Symposium)
	13:30	Clinical parasitology in western hospitals: the essentials (Official Symposium)
	13:30	Hot topics in retrovirology (Official Symposium)
	13:30	Bloodstream infection - epidemiology and management (Official Symposium)
	13:30	KPC beta-lactamases (Oral session)
	13:30	Bacterial pathogenesis: what is new (from virulence factors to biofilm)? (Oral session)
	13:30	Old and new strategies targeting healthcare associated infections: where do we stand? (Oral session)
	13:30	Finding better strategies to use antibiotics (Oral session)
	13:30	Clostridium difficile infection (Oral session)